These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32733273)

  • 1. Suppressed Vascular Leakage and Myocardial Edema Improve Outcome From Myocardial Infarction.
    Li X; Redfors B; Sáinz-Jaspeado M; Shi S; Martinsson P; Padhan N; Scharin Täng M; Borén J; Levin M; Claesson-Welsh L
    Front Physiol; 2020; 11():763. PubMed ID: 32733273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread.
    Li X; Padhan N; Sjöström EO; Roche FP; Testini C; Honkura N; Sáinz-Jaspeado M; Gordon E; Bentley K; Philippides A; Tolmachev V; Dejana E; Stan RV; Vestweber D; Ballmer-Hofer K; Betsholtz C; Pietras K; Jansson L; Claesson-Welsh L
    Nat Commun; 2016 Mar; 7():11017. PubMed ID: 27005951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
    Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
    Elife; 2020 Apr; 9():. PubMed ID: 32312382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Vascular Endothelial Growth Factor (VEGF) Receptor 2 Mediates Endothelial Permeability Caused by Cyclic Stretch.
    Tian Y; Gawlak G; O'Donnell JJ; Birukova AA; Birukov KG
    J Biol Chem; 2016 May; 291(19):10032-45. PubMed ID: 26884340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting VEGF-A/VEGFR2 Y949 Signaling-Mediated Vascular Permeability Alleviates Hypoxic Pulmonary Hypertension.
    Zhou W; Liu K; Zeng L; He J; Gao X; Gu X; Chen X; Jing Li J; Wang M; Wu D; Cai Z; Claesson-Welsh L; Ju R; Wang J; Zhang F; Chen Y
    Circulation; 2022 Dec; 146(24):1855-1881. PubMed ID: 36384284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of angiopoietin-like 4 slows ovarian cancer progression through vascular endothelial growth factor receptor 2 phosphorylation.
    Wu Y; Gao J; Liu X
    Cancer Cell Int; 2021 Mar; 21(1):171. PubMed ID: 33726754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd.
    Sun Z; Li X; Massena S; Kutschera S; Padhan N; Gualandi L; Sundvold-Gjerstad V; Gustafsson K; Choy WW; Zang G; Quach M; Jansson L; Phillipson M; Abid MR; Spurkland A; Claesson-Welsh L
    J Exp Med; 2012 Jul; 209(7):1363-77. PubMed ID: 22689825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VE-cadherin junction dynamics in initial lymphatic vessels promotes lymph node metastasis.
    Sáinz-Jaspeado M; Ring S; Proulx ST; Richards M; Martinsson P; Li X; Claesson-Welsh L; Ulvmar MH; Jin Y
    Life Sci Alliance; 2024 Mar; 7(3):. PubMed ID: 38148112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice.
    Besnier M; Galaup A; Nicol L; Henry JP; Coquerel D; Gueret A; Mulder P; Brakenhielm E; Thuillez C; Germain S; Richard V; Ouvrard-Pascaud A
    FASEB J; 2014 Aug; 28(8):3351-61. PubMed ID: 24760754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
    Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
    Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells.
    Nakamura Y; Patrushev N; Inomata H; Mehta D; Urao N; Kim HW; Razvi M; Kini V; Mahadev K; Goldstein BJ; McKinney R; Fukai T; Ushio-Fukai M
    Circ Res; 2008 May; 102(10):1182-91. PubMed ID: 18451337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4.
    Galaup A; Gomez E; Souktani R; Durand M; Cazes A; Monnot C; Teillon J; Le Jan S; Bouleti C; Briois G; Philippe J; Pons S; Martin V; Assaly R; Bonnin P; Ratajczak P; Janin A; Thurston G; Valenzuela DM; Murphy AJ; Yancopoulos GD; Tissier R; Berdeaux A; Ghaleh B; Germain S
    Circulation; 2012 Jan; 125(1):140-9. PubMed ID: 22086875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organs.
    Sidibé A; Polena H; Pernet-Gallay K; Razanajatovo J; Mannic T; Chaumontel N; Bama S; Maréchal I; Huber P; Gulino-Debrac D; Bouillet L; Vilgrain I
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H455-63. PubMed ID: 24858856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losartan protects against myocardial ischemia and reperfusion injury
    Li Y; Yao Y; Li J; Chen Q; Zhang L; Wang QK
    FASEB J; 2019 Jul; 33(7):8555-8564. PubMed ID: 30991833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyocyte A Disintegrin And Metalloproteinase 17 (ADAM17) Is Essential in Post-Myocardial Infarction Repair by Regulating Angiogenesis.
    Fan D; Takawale A; Shen M; Wang W; Wang X; Basu R; Oudit GY; Kassiri Z
    Circ Heart Fail; 2015 Sep; 8(5):970-9. PubMed ID: 26136458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src.
    Sjöberg E; Melssen M; Richards M; Ding Y; Chanoca C; Chen D; Nwadozi E; Pal S; Love DT; Ninchoji T; Shibuya M; Simons M; Dimberg A; Claesson-Welsh L
    J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37651195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of Extracellular RNA Reduces Edema Formation and Infarct Size and Improves Survival After Myocardial Infarction in Mice.
    Stieger P; Daniel JM; Thölen C; Dutzmann J; Knöpp K; Gündüz D; Aslam M; Kampschulte M; Langheinrich A; Fischer S; Cabrera-Fuentes H; Wang Y; Wollert KC; Bauersachs J; Braun-Dullaeus R; Preissner KT; Sedding DG
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28637776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIF13B mediates VEGFR2 recycling to modulate vascular permeability.
    Cho HD; Nhàn NTT; Zhou C; Tu K; Nguyen T; Sarich NA; Yamada KH
    Cell Mol Life Sci; 2023 Mar; 80(4):91. PubMed ID: 36928770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor.
    Ha CH; Bennett AM; Jin ZG
    J Biol Chem; 2008 Mar; 283(11):7261-70. PubMed ID: 18180305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HLA I antibodies induce VEGF production by endothelial cells, which increases proliferation and paracellular permeability.
    Bieri M; Oroszlan M; Farkas A; Ligeti N; Bieri J; Mohacsi P
    Int J Biochem Cell Biol; 2009 Dec; 41(12):2422-30. PubMed ID: 19577661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.